MedTrace Logo

High Dose Nimodipine Treatment Adjunct - 1

NCT00000332 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2017-02-24

No results posted yet for this study

Summary

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Nimodipine

Sponsors & Collaborators

  • Washington D.C. Veterans Affairs Medical Center

    collaborator FED

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Steven Deutsch, M.D. · Washington D.C. Veterans Affairs Medical Center

Study Design

Purpose
TREATMENT

Eligibility

Min Age
22 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-05-31
Primary Completion
2000-01-31
Completion
2000-04-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000332 on ClinicalTrials.gov